Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electronic S3 Prediction of Hospital Readmissions for Heart Failure Exacerbation

NCT04112849 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.

NCT NCT04112849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04112849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electronic S3 Prediction of Hospital Readmissions for Heart Failure Exacerbation
Lead sponsor
Milton S. Hershey Medical Center
Phase
Observational
Overall status
Completed
Start date
March 11, 2020
Completion date
September 1, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction